凯西莱在肝癌介入化疗中保肝作用的研究  

Study on the Action of Tiopronin during Chemotherapy Intervention of Hepatocarcinoma

作　　者：李威[1] 李大伟[1] 

机构地区：[1]黑龙江省医院介入科,黑龙江哈尔滨150036

出　　处：《黑龙江医学》2005年第5期352-352,共1页Heilongjiang Medical Journal

摘　　要：目的观察凯西莱在肝癌介入中对肝的保护作用。方法肝癌介入治疗后,静脉点滴凯西莱。结果同常规保肝药相比凯西莱能更快恢复肝脏功能,且有效率较高。结论凯西莱对肝癌介入治疗后肝功有较好的保护作用。Objective To observe the protective action for liver during the chemotherapy interventional therapy of hepatocarcinoma. Methods The tiopronin was injected after hepatocarcinoma intervention therapy. Results The tiopronin could recover the hepatic function than routine drug that helpful for liver with high effective. Conclusion Tiopronin might have better protective action for liver during hepatocarcinoma interventional therapy.

关 键 词：肿瘤学 凯西莱 肝癌介入治疗 保肝作用 

分 类 号：R735.7[医药卫生—肿瘤]